Showing results (321-330 of 447) with videos related to
Sort By:
Pageof 45
Lung Cancer (Amsterdam, Netherlands)|June 11, 2020
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerRuoshi Shi, Sebastiao N Martins Filho, Ming Li, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
The International Association for the Study of Lung Cancer Staging Project: The Database and Proposal for the Revision of the Staging of Pulmonary Neuroendocrine Carcinoma in the Forthcoming Ninth Edition of the TNM Classification for Lung CancerMing Sound Tsao, Adam Rosenthal, Andrew G Nicholson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
Organoid Cultures as Preclinical Models of Non-Small Cell Lung CancerRuoshi Shi, Nikolina Radulovich, Christine Ng, et al.Plos One|September 9, 2020
Cancer proteome and metabolite changes linked to SHMT2Jiefei Tong, Jonathan R Krieger, Paul Taylor, et al.Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 studyGlenwood D Goss, Chris O'Callaghan, Ian Lorimer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Integrating RAS status into prognostic signatures for adenocarcinomas of the lungMaud H W Starmans, Melania Pintilie, Michelle Chan-Seng-Yue, et al.The Lancet. Digital Health|September 1, 2020
Prediction of lung cancer risk at follow-up screening with low-dose CT: a training and validation study of a deep learning methodPeng Huang, Cheng T Lin, Yuliang Li, et al.Cancer Epidemiology|January 28, 2016
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patientsSinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, et al.Archives of Pathology & Laboratory Medicine|January 19, 2016
Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology SocietyLynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.Pageof 45